Sinha Uma

CIK 00017425873 companiesWINSTON SALEM, NC

SEC Profile

Transactions

Companies

Filings

CIK

0001742587

Recent Transactions

50 trades

Award
PROKIDNEY CORP.$PROK
Director stock option (right to buy)
2025-05-29+125,862→ 125,862 total
Award
PROKIDNEY CORP.$PROK
Director stock option (right to buy)
2024-05-30+62,558→ 62,558 total
Award
PROKIDNEY CORP.$PROK
Director stock option (right to buy)
2023-06-29+48,128→ 48,128 total
Award
PROKIDNEY CORP.$PROK
Class A Ordinary Shares
2022-07-11+30,000→ 30,000 total
Disposition from Tender
Eidos Therapeutics, Inc.
Common Stock
2021-01-26−303,525→ 0 total
Disposition to Issuer
Eidos Therapeutics, Inc.
Stock Option (Right to Buy)
2021-01-26−60,000→ 0 total
Sale
Eidos Therapeutics, Inc.
Common Stock
2021-01-13$123.48/sh−1,498→ 313,759 total
Sale
Eidos Therapeutics, Inc.
Common Stock
2021-01-13$126.39/sh−300→ 306,525 total
Sale
Eidos Therapeutics, Inc.
Common Stock
2021-01-13$121.11/sh−696→ 315,829 total
Sale
Eidos Therapeutics, Inc.
Common Stock
2021-01-13$125.35/sh−2,000→ 306,825 total
Sale
Eidos Therapeutics, Inc.
Common Stock
2021-01-13$122.27/sh−572→ 315,257 total
Sale
Eidos Therapeutics, Inc.
Common Stock
2021-01-13$124.72/sh−4,934→ 308,825 total
Award
BridgeBio Pharma, Inc.$BBIO
Stock Option (Right to Buy)
2020-12-15+5,717→ 5,717 total
Award
BridgeBio Pharma, Inc.$BBIO
Stock Option (Right to Buy)
2020-12-15+8,912→ 8,912 total
Award
BridgeBio Pharma, Inc.$BBIO
Stock Option (Right to Buy)
2020-12-15+10,832→ 10,832 total
Sale
Eidos Therapeutics, Inc.
Common Stock
2020-12-02$92.97/sh−200→ 316,525 total
Sale
Eidos Therapeutics, Inc.
Common Stock
2020-12-02$91.89/sh−300→ 316,725 total
Sale
Eidos Therapeutics, Inc.
Common Stock
2020-12-02$90.63/sh−702→ 317,025 total
Sale
Eidos Therapeutics, Inc.
Common Stock
2020-12-02$89.63/sh−3,798→ 317,727 total
Exercise/Conversion
BridgeBio Pharma, Inc.$BBIO
Common Stock
2020-11-16+469→ 16,460 total
Exercise/Conversion
BridgeBio Pharma, Inc.$BBIO
Restricted Stock Units
2020-11-16−469→ 6,563 total
Sale
Eidos Therapeutics, Inc.
Common Stock
2020-10-29$72.60/sh−3,700→ 321,525 total
Sale
Eidos Therapeutics, Inc.
Common Stock
2020-10-29$71.90/sh−1,300→ 325,225 total
Gift
Eidos Therapeutics, Inc.
Common Stock
2020-10-27−3,000→ 303,525 total
Sale
Eidos Therapeutics, Inc.
Common Stock
2020-10-01$52.35/sh−4,831→ 326,525 total
Sale
Eidos Therapeutics, Inc.
Common Stock
2020-09-30$52.08/sh−69→ 331,456 total
Sale
Eidos Therapeutics, Inc.
Common Stock
2020-09-30$52.00/sh−100→ 331,356 total
Exercise/Conversion
BridgeBio Pharma, Inc.$BBIO
Common Stock
2020-08-16+468→ 15,991 total
Exercise/Conversion
BridgeBio Pharma, Inc.$BBIO
Restricted Stock Units
2020-08-16−468→ 7,032 total
Award
BridgeBio Pharma, Inc.$BBIO
Restricted Stock Units
2020-06-01+7,500→ 7,500 total
Award
Eidos Therapeutics, Inc.
Common Stock
2020-05-31$41.57/sh+444→ 331,525 total
Award
BridgeBio Pharma, Inc.$BBIO
Stock Option (Right to Buy)
2020-05-19+49,361→ 49,361 total
Award
BridgeBio Pharma, Inc.$BBIO
Stock Option (Right to Buy)
2020-05-19+3,022→ 3,022 total
Award
BridgeBio Pharma, Inc.$BBIO
Stock Option (Right to Buy)
2020-05-19+5,366→ 5,366 total
Award
BridgeBio Pharma, Inc.$BBIO
Common Stock
2020-05-19+1,523→ 15,523 total
Award
BridgeBio Pharma, Inc.$BBIO
Stock Option (Right to Buy)
2020-05-19+49,765→ 49,765 total
Sale
Eidos Therapeutics, Inc.
Common Stock
2019-12-18$63.31/sh−1,702→ 331,081 total
Sale
Eidos Therapeutics, Inc.
Common Stock
2019-12-18$61.61/sh−9,973→ 333,608 total
Sale
Eidos Therapeutics, Inc.
Common Stock
2019-12-18$62.49/sh−825→ 332,783 total
Sale
Eidos Therapeutics, Inc.
Common Stock
2019-09-25$39.15/sh−100→ 343,581 total
Sale
Eidos Therapeutics, Inc.
Common Stock
2019-09-25$38.38/sh−2,400→ 343,681 total
Sale
Eidos Therapeutics, Inc.
Common Stock
2019-07-25$35.65/sh−2,967→ 348,114 total
Sale
Eidos Therapeutics, Inc.
Common Stock
2019-07-25$37.31/sh−700→ 346,114 total
Sale
Eidos Therapeutics, Inc.
Common Stock
2019-07-25$38.35/sh−33→ 346,081 total
Sale
Eidos Therapeutics, Inc.
Common Stock
2019-07-25$36.53/sh−1,300→ 346,814 total
Purchase
BridgeBio Pharma, Inc.$BBIO
Common Stock
2019-07-01$17.00/sh+14,000→ 14,000 total
Award
Eidos Therapeutics, Inc.
Common Stock
2019-05-31$12.01/sh+1,769→ 351,081 total
Sale
Eidos Therapeutics, Inc.
Common Stock
2019-05-23$27.88/sh−800→ 349,312 total
Sale
Eidos Therapeutics, Inc.
Common Stock
2019-05-23$27.16/sh−4,200→ 350,112 total
Award
Eidos Therapeutics, Inc.
Common Stock
2018-11-30$12.01/sh+1,081→ 354,312 total

Companies

Recent Filings

Address

C/O PROKIDNEY CORP 2000 FRONTIS PLAZA BLVD, SUITE 250

WINSTON SALEM, NC, 27103

View on SEC.gov